[go: up one dir, main page]

JP2000509036A - 安定化された抗ｂ型肝炎ワクチンタブレット - Google Patents

安定化された抗ｂ型肝炎ワクチンタブレット

Info

Publication number
JP2000509036A
JP2000509036A JP9537890A JP53789097A JP2000509036A JP 2000509036 A JP2000509036 A JP 2000509036A JP 9537890 A JP9537890 A JP 9537890A JP 53789097 A JP53789097 A JP 53789097A JP 2000509036 A JP2000509036 A JP 2000509036A
Authority
JP
Japan
Prior art keywords
hepatitis
protein
tablet
antigenic
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9537890A
Other languages
English (en)
Japanese (ja)
Inventor
ピーター・アール・ロスチャイルド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2000509036A publication Critical patent/JP2000509036A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP9537890A 1996-04-22 1997-03-31 安定化された抗ｂ型肝炎ワクチンタブレット Pending JP2000509036A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63551496A 1996-04-22 1996-04-22
US08/635,514 1996-04-22
PCT/IB1997/000448 WO1997039762A1 (fr) 1996-04-22 1997-03-31 Comprimes de vaccin contre l'hepatite b stabilises

Publications (1)

Publication Number Publication Date
JP2000509036A true JP2000509036A (ja) 2000-07-18

Family

ID=24548102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9537890A Pending JP2000509036A (ja) 1996-04-22 1997-03-31 安定化された抗ｂ型肝炎ワクチンタブレット

Country Status (8)

Country Link
EP (1) EP0914141A1 (fr)
JP (1) JP2000509036A (fr)
KR (1) KR20000010591A (fr)
CN (1) CN1216471A (fr)
AU (1) AU2520397A (fr)
CA (1) CA2285184A1 (fr)
HU (1) HUP9902293A3 (fr)
WO (1) WO1997039762A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT1212045T (lt) * 1999-08-24 2016-12-12 Abic Biological Laboratories Ltd. Vakcinos kompozicija ir jos panaudojimas
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
ES2108258T3 (es) * 1992-01-17 1997-12-16 Alfatec Pharma Gmbh Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.

Also Published As

Publication number Publication date
CN1216471A (zh) 1999-05-12
HUP9902293A2 (hu) 1999-11-29
EP0914141A1 (fr) 1999-05-12
CA2285184A1 (fr) 1997-10-30
AU2520397A (en) 1997-11-12
KR20000010591A (ko) 2000-02-15
HUP9902293A3 (en) 2000-04-28
WO1997039762A1 (fr) 1997-10-30

Similar Documents

Publication Publication Date Title
DE68927679T2 (de) Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
TWI284041B (en) Freeze-dried pantoprazole preparation and pantoprazole injection
US5081156A (en) Sustained-release preparation
CA2288143A1 (fr) Formulations de proteine activee
JPH09503754A (ja) 初乳から免疫グロブリンを得る方法および医薬組成物におけるそれらの使用
JPS6013718A (ja) Ｂ型肝炎ワクチン
TWI243057B (en) Formulations for protection of peg-interferon alpha conjugates
KR101117861B1 (ko) 포르시토사이드 주사제와 그 제조 방법
JP2002500622A (ja) ロタウイルスワクチン製剤類
JPS59181224A (ja) 安定なインタ−フエロン製剤の製法
JPH03173829A (ja) 安定な経口投与用免疫原組成物
CA1214102A (fr) Preparation pharmaceutique contenant de la fibronectine purifiee
DE3601923A1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
AP1168A (en) Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets.
JP2000509036A (ja) 安定化された抗ｂ型肝炎ワクチンタブレット
HU205555B (en) Process for producing stabilized leukocyte interferons
US20240189234A1 (en) Silicon particles for drug delivery
JPS58146504A (ja) α―インターフェロン製剤およびその製造方法
JP2001526662A (ja) 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
CN103330933A (zh) 含有米卡芬净或其盐的药物组合物
RU2185807C1 (ru) Пролонгированные лекарственные формы местного действия, оказывающие активирующее влияние на иммунную систему
JPS60224634A (ja) 吸入アレルゲンを含有するアレルギー治療用リポソーム
JPH06340549A (ja) ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法
CN101756912B (zh) 一种蛇毒凝血酶冻干粉针剂及其制备方法
JPS62153224A (ja) プラスミノゲン製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040331

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20040921